In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Oxford Nanopore brings in $109mm via late-stage funding round

Executive Summary

In what looks to be its Series J financing round, Oxford Nanopore Technologies Ltd. (nanopore-based molecular electronic analysis systems) raised £70mm ($109mm) through the sale of ordinary shares to new and existing investors in the UK, US, and Europe. Proceeds will support product development, manufacturing, and commercialization.
Deal Industry
  • Research, Analytical Equipment & Supplies
  • Biotechnology
    • Nanotechnology, Chips, etc.
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies